Methods for increasing the diversity of monoclonal antibodies produced against an antigen

Details for Australian Patent Application No. 2005295921 (hide)

Owner Acton Biotech Consulting

Inventors Cumming, Dale Anthony

Agent Spruson & Ferguson

Pub. Number AU-B-2005295921

PCT Pub. Number WO2006/044336

Priority 60/617,859 12.10.04 US

Filing date 12 October 2005

Wipo publication date 27 April 2006

Acceptance publication date 12 May 2011

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/044336 Priority application(s): WO2006/044336

7 October 2010 Assignment before Grant

  Translational Medicines, Inc. The application has been assigned to Action Biotech Consulting

12 May 2011 Application Accepted

  Published as AU-B-2005295921

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295925-Coating compositions, articles, and methods of coating articles

2005295919-Platelet-derived growth factor compositions and methods of use thereof